President Donald Trump signed an executive order permitting the broader use of red-dyed diesel, a cheaper, tax-exempt fuel usually reserved for farms and construction, to help lower soaring fuel prices. This move comes as the US diesel price hit a record $6 per gallon due to global supply constraints linked to the Ukraine war and refining shortages. The order also defers federal excise taxes on highway diesel through the end of 2026 and explores eliminating these taxes altogether. This measure aims to reduce costs for truckers and farmers, potentially saving over $100 per fill-up, while the government and G7 nations work to stabilize fuel supplies.
Regarding President Donald Trump's executive order on cheaper, dyed diesel, here is Pluang's market snapshot as of Oct 06, 2026 11:51 WIB: Out of 150 priced US stocks tradable on Pluang, 102 rose and 42 fell today. Notable movers include Cenovus Energy Inc (CVE) at USD 31.45 with a 1-day change of -2.93%, PayPal Holdings, Inc. (PYPL) at USD 54.33 up 2.90%, and Block Inc (XYZ) at USD 76.39 up 2.77%. The most notable figure is PayPal's 72% sell order activity on Pluang.
Ethereum (ETH) maintained stability above $2,700, marking its first weekly close above this level in nine months, signaling renewed bullish sentiment. Treasury firm BitMine expanded its Ethereum holdings by 15,112 ETH, now controlling about 4.9% of t...
Bitcoin options markets have shifted toward a bullish stance, with one-week 25-delta call options now more in demand than puts, indicating traders expect price gains. This shift, first seen in August 2026, shows calls making up about 61.4% of open in...
Binance experienced a net outflow of approximately 40,000 Bitcoin over a 15-day period, reducing its reserves from 704,800 BTC to 663,100 BTC. The weekly net outflow hit 23,100 BTC, the highest since June 2023, with a daily peak of 14,300 BTC on Octo...
Nebius Group N.V. is rated a buy due to its strategic partnership with Palantir, which positions Nebius as the preferred sovereign infrastructure provider for Palantir's enterprise AI solutions targeting regulated industries. This collaboration allow...
Poolbeg Pharma has obtained a South Korean patent for POLB 001, a treatment designed to prevent cytokine release syndrome (CRS), a serious side effect of cancer immunotherapy. The patent covers the use of p38 MAP kinase inhibitors to prevent CRS and ...
